Thermo Fisher Scientific (NYSE:TMO) said today that its TaqPath diagnostic kit can detect the emerging Omicron variant of COVID-19. Waltham, Massachusetts-based Thermo Fisher’s polymerase chain reaction (PCR) TaqPath COVID-19 Combo Kit and TaqPath COVID-19 CE-IVD RT-PCR Kit, which test for the presence of SARS-CoV-2 (the virus causing COVID-19), offer accurate results for samples with the […]
Thermo Fisher Scientific
Medtech M&A: The industry’s biggest mergers and acquisitions of 2021
Across 2021, medtech has seen a wide range of mergers and acquisitions covering several areas of devices, pharmaceuticals and more. Some have gone off without a hitch, while others fell into serious scrutiny as mouthwatering financial figures were revealed and major technologies were acquired. Here are the 10 biggest mergers and acquisitions in medtech in […]
Thermo Fisher Scientific ticks up on Street-beating Q3 results
Thermo Fisher Scientific (NYSE:TMO) today posted third-quarter results that beat the overall consensus on Wall Street. The Waltham, Massachusetts–based laboratory supply company reported profits of $1.9 billion, or $4.79 per share, on sales of $9.3 billion for the three months ended October 2, for a bottom-line loss of -1.6% on sales growth of 9.49% compared with […]
Thermo Fisher Scientific beats The Street in Q2 results
Thermo Fisher Scientific (NYSE:TMO) today posted second-quarter results that beat the overall consensus on Wall Street. The Waltham, Mass.–based company reported profits of $1.8 billion, or $4.61 per share, on sales of $9.3 billion for the three months ended July 1, 2021, for a bottom-line gain of 58.1% on sales growth of 34.1% compared with Q2 […]
MedTech 100 roundup: Industry skies to all-time high
The medtech industry hit a slight lull in the early stages of 2021 and, after signs of a rebound, it has soared beyond levels ever before seen. MassDevice‘s MedTech 100 Index had been building up steam in the month of April, rising from 102.16 points at the beginning of March all the way to 109.39 to […]
Thermo Fisher to buy PPD for $17B
Thermo Fisher Scientific (NYSE:TMO) announced today that it agreed to acquire PPD (NSDQ:PPD) for $17.4 billion. The boards of directors for both companies approved the definitive agreement, which will see Thermo Fisher buy PPD for $47.50 per share, totaling $17.4 billion, plus the assumption of approximately $3.5 billion of net debt, according to a news […]
DTW Podcast – CEO MacMillan on how COVID-19 strengthened Hologic
Hologic CEO Steve MacMillan says in early March 2020 he didn’t appreciate how COVID-19 would change the world forever. But the diagnostics company quickly rose to the challenge, becoming one of the surer suppliers of diagnostic tests needed to chart the coronavirus’s severity. In this DeviceTalks Weekly podcast, MacMillan shares how Hologic pivoted to meet […]
Thermo Fisher Scientific, Mayo Clinic partner on new diagnostic tools
Thermo Fisher Scientific and Mayo Clinic today announced a new collaboration that will take place near the respected health provider’s main Rochester, Minn. campus. The partnership will focus on accelerating clinical validation and commercialization of certain next-generation sequencing (NGS), mass spectrometry and immunology diagnostic tools. Work will occur at the Advanced Diagnostics Laboratory at the 90,000-square-foot […]
Thermo Fisher launches device that can detect COVID-19 in the air
Thermo Fisher Scientific (NYSE:TMO) today announced the launch of its toaster-oven-sized Thermo Scientific AerosolSense Sampler, which can help detect airborne pathogens including the virus that causes COVID-19. The AerosolSense Sampler collects representative aerosol samples of ambient air and traps in-air pathogens on a collection substrate. The sample can be readily analyzed through subsequent laboratory testing […]
MedTech 100 Roundup: Small slide continues
On the back of several weeks of new records and strong performances, the medtech industry has finally hit a snag in its recent ascent. MassDevice‘s MedTech 100 index ended the week (Feb. 26) at 106.65 points, marking a 1.9% dip from the 108.72-point mark set one week before (Feb. 19). This highlights a similar drop from […]
Thermo Fisher completes Mesa Biotech acquisition
Thermo Fisher Scientific (NYSE:TMO) announced today that it completed its previously announced acquisition of Mesa Biotech. Last month, Waltham, Mass.-based Thermo Fisher announced its agreement to buy the point-of-care molecular diagnostic developer for approximately $450 million in cash. Mesa Biotech will become part of Thermo Fisher’s life sciences solution segment and is expected to bring […]